(via Twitter/@the_new_age)

The settlement also includes paying for charges in which the company would send kickbacks to doctors and pharmacies promoting their drugs. 

This is one of the largest settlements reported in terms of illegal drug marketing.  

Attorney General Eric H. Holder said, “The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust.” 

The drug Risperdal, for example, is only approved to use in treatment of schizophrenia. However, the drug was marketed by Johnson & Johnson to treat anxiety, agitation, and depression among other symptoms. 

Johnson & Johnson will also have to sign a Corporate Integrity Agreement with the Department of Health and Human Services. The agreement will insure future accountability and prevent further fraud and abuse of power. 

Reach Executive Producer Jillian Morabito here.